Fluorine-18 prostate-specific membrane antigen–1007 PET/CT vs multiparametric MRI for locoregional staging of prostate cancer

JAMA Oncology

2024-07-01

(Press-News.org) About The Study: In this phase 2 prospective validating paired cohort study, fluorine-18 PSMA-1007 PET/computed tomography was superior to magnetic resonance imaging (MRI) for the locoregional staging of prostate cancer. These findings support PSMA PET in the preoperative workflow of intermediate-risk and high-risk tumors.

Corresponding Author: To contact the corresponding author, Adam Kinnaird, M.D., Ph.D., email ask@ualberta.ca.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoncol.2024.3196)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being presented at the Canadian Urological Association Annual Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.3196?guestAccessKey=2cd3fc6c-d9db-487f-9ba5-c3d143791b17&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070124

END

ELSE PRESS RELEASES FROM THIS DATE:

Xue to receive funding for project aimed at youth tobacco use prevention

2024-07-01

Hong Xue, Associate Professor, Health Administration and Policy, received funding for the project: “Innovating and Implementing Youth Tobacco Prevention in Virginia.” Xue will leverage the forefront of technological innovation, utilizing generative artificial intelligence (AI) and state-of-the-art immersive technologies, integrating them with novel just-in-time adaptive intervention strategies, to tackle the pressing public health issue of electronic cigarette/tobacco use among the youth in Virginia. Xue will receive $450,000 from Virginia ...

Petricoin conducting protein pathway activation based signaling mapping of head and neck cancers

2024-07-01

Emanuel Petricoin, Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), received funding for the project: “Protein Pathway Activation Based Signaling Mapping of Head And Neck Cancers.” CAPMM researchers will receive laser microdissected tumor samples from banked Formalin-Fixed Paraffin-Embedded (FFPE) clinical biopsy samples from patients with HPV‐positive head and neck cancers who were treated for newly diagnosed disease. The researchers will utilize comprehensive reverse‐phase ...

Marasco studying inclusive design of contactless fingerprints to mitigate skin tone and gender bias

2024-07-01

Emanuela Marasco, Assistant Professor, Center for Secure Information Systems, received funding for the project: “Identity Verification in Smartphones as Social Intersectionality: Inclusive Design of Contactless Fingerprints to Mitigate Skin Tone and Gender Bias.” She is developing a contactless biometric mobile security application that can mitigate the vulnerabilities of deep artificial intelligence and optical sensors and allow marginalized identities the same access to data security. As part of their work, members of the project team will identify the impact of physical vulnerabilities; their ...

Physical exercise prevents nerve damage during chemotherapy

2024-07-01

Cancer treatments often cause nerve damage that can lead to long-lasting symptoms. Medication has proven ineffective in these cases. A sports scientist at the University of Basel, together with an interdisciplinary team from Germany, has now shown that simple exercises can prevent nerve damage. Cancer therapies have improved over the years. It is no longer just about sheer survival: quality of life after recovery is gaining more importance. Unfortunately, many cancer medications, from chemotherapy to modern immunotherapies, attack the nerves as well as the tumor cells. Some therapies, such as oxaliplatin or vinca alkaloids, leave 70 to 90 percent of patients complaining of pain, balance ...

Scientists turn white fat cells into calorie-burning beige fat

2024-07-01

New UCSF study shows that suppressing a protein turns ordinary fat into a calorie burner and may explain why drug trials attempting the feat haven’t been successful. Researchers at UC San Francisco have figured out how to turn ordinary white fat cells, which store calories, into beige fat cells that burn calories to maintain body temperature. The discovery could open the door to developing a new class of weight-loss drugs and may explain why clinical trials of related therapies have ...

How politicizing migration harms health

2024-07-01

Politicians around the world are increasingly mobilizing anti-immigrant sentiment to garner support and votes—a trend that is especially evident as the US presidential election approaches. While political rhetoric that stereotypes and scapegoats immigrants is well-documented, less attention has been given to the impact of these sentiments on immigrants themselves. In an article published today in the Journal of the American Medical Association (JAMA) and in a recently published book, Migration Stigma (MIT Press), scholars identify “migration ...

Excess US deaths attributable to high all-cause mortality rates among youths

2024-07-01

About The Study: The mortality gap between the U.S. and comparison countries widened in the last decade. Each year, nearly 20,000 deaths among youths ages 0 to 19 years would not have occurred had U.S. youths experienced the median mortality rates of 16 comparison countries. More than half of these deaths involved infants, reflecting disproportionately high U.S. infant mortality rates. Corresponding Author: To contact the corresponding author, Steven H. Woolf, M.D., M.P.H., email steven.woolf@vcuhealth.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2024.1869) Editor’s ...

COVID-19 vaccination in the first trimester and major structural birth defects among live births

2024-07-01

About The Study: Among live-born infants, first-trimester mRNA COVID-19 vaccine exposure was not associated with an increased risk for selected major structural birth defects in this multisite cohort study. Corresponding Author: To contact the corresponding author, Elyse O. Kharbanda, M.D., M.P.H., email elyse.o.kharbanda@healthpartners.com. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2024.1917) Editor’s Note: Please see the article for additional ...

Dehumanizing rhetoric on immigration harms public health

2024-07-01

With Donald Trump and other right-wing politicians increasingly using dehumanizing rhetoric to stigmatize immigrants coming to our nation's borders, doctors and other health officials should prepare for the resulting health consequences. Such is the message of a “Viewpoint” article co-authored by UC Riverside professor Bruce Link and published Monday, July 1, in the Journal of the American Medical Association. Link and his co-authors quote Trump as saying, “No, they’re not humans. They’re not humans. They’re ...

A prosthesis driven by the nervous system helps people with amputation walk naturally

2024-07-01

State-of-the-art prosthetic limbs can help people with amputations achieve a natural walking gait, but they don’t give the user full neural control over the limb. Instead, they rely on robotic sensors and controllers that move the limb using predefined gait algorithms. Using a new type of surgical intervention and neuroprosthetic interface, MIT researchers, in collaboration with colleagues from Brigham and Women’s Hospital, have shown that a natural walking gait is achievable using a prosthetic leg fully driven by the body’s own nervous system. ...

Fluorine-18 prostate-specific membrane antigen–1007 PET/CT vs multiparametric MRI for locoregional staging of prostate cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: